🚀 New Report Alert! Our 2024 Payer Oncology Trend Report is here, offering crucial insights from 50 Medical and Pharmacy Directors. Discover how payer perspectives are shifting and what this means for you and your teams in 2025. Reach out to Ramon Auciello for more information! #PayerOncologyTrendReport #Oncology #PayerInsights #HealthcareTrends #HMPMarketAccessInsights 

Your oncology trial could make a difference in countless lives, and you should be empowered to embark on your trial journey with confidence. Don’t compromise your clinical trial before it begins. Experience matters. Trust Clario. Clario’s expertise revolutionizes what’s possible. From new trial methodologies to faster and integrated evidence and findings, our innovative oncology trial solutions ensure we deliver the regulatory compliant data you need. Learn more about the difference Clario can make for your next trial. Visit https://lnkd.in/ebwreQ8u #ClinicalTrials #Oncology #ClinicalResearch

Did you know that 41% of oncology studies use a Data Monitoring Committee (DMC), compared to just 34% of non-oncology studies? Discover the critical role DMCs play in ensuring safety and success in oncology trials. Our experts will dive into best practices, key challenges, and innovative approaches for managing complex data in oncology studies. 🗓️ Date: September 20, 2023 ⏰ Time: 11 AM EDT Take advantage of this opportunity to enhance your understanding of oncology study oversight! Register here: https://bit.ly/3ZeEJYG #OncologyResearch #ClinicalTrials #DMCs #Webinar #LifeSciences

If you have an oncology study requiring a DMC in your future, register below for Cytel's upcoming webinar to learn about how the DMC can be as effective as possible.

#Oncology #clinicaltrials have many unique elements. #Sponsors need flexible technology to meet the rapidly changing requirements of the study, #site, and most of all -- #Patients.

Advanced #IRT systems tackle the challenges #oncology trial sponsors face, ensuring trials stay on track and patients continue treatment,despite changes. Learn more in this article by Malcolm Morrissey. https://lnkd.in/gicEiM65 #ClinicalTrials #Randomization #TrialSupplyManagement #CalyxIRT #ChooseCalyx #RTSM

Did you know that there are over 14,000 active oncology trials right now? These trials are advancing new treatments and giving hope to patients around the world and in your community. With just a quick share, you can help spread awareness. https://ow.ly/KcL150Qwx1x #cancerawareness #oncologytrials #clinicaltrials

Your oncology trial could make a difference in countless lives, and you should be empowered to embark on your trial journey with confidence. Don’t compromise your clinical trial before it begins. Experience matters. Trust Clario. Clario’s expertise revolutionizes what’s possible. From new trial methodologies to faster and integrated evidence and findings, our innovative oncology trial solutions ensure we deliver the regulatory compliant data you need. Learn more about the difference Clario can make for your next trial. Visit https://lnkd.in/erXxPS6J #ClinicalTrials #Oncology

Did your organization apply for the reopened Enhancing Oncology Model (EOM)? In a recent Canopy webinar, thought leaders from CMS and community oncology shared helpful insights and strategies for success in the EOM and other value-based programs. Catch the full discussion to learn more: https://lnkd.in/ekfjd6V4

Notable Labs’ Strategic Growth in 2023 CEO Thomas Bock reflects on our achievements: a successful transition to a publicly traded company, strong financial performance, and pivotal clinical trials. As we advance the Volasertib program and continue our mission in precision oncology, we're committed to improving patient outcomes. Follow @notablelabs for the latest updates! #PrecisionMedicine #Oncology #BusinessUpdate